Study Evaluating Neratinib Versus Lapatinib Plus Capecitabine For ErbB2 Positive Advanced Breast Cancer

计划入组 233 人 · 首次发布于 2008 年 10 月 22 日

ErbB2 Positive Metastatic Breast Cancer

计划入组 15 人 · 首次发布于 2012 年 8 月 7 日

Brain Metastases In ErbB2-Positive Breast Cancer

计划入组 22 人 · 首次发布于 2007 年 2 月 19 日

Breast cancer (BreakBio)

breast cancer vaccine

Breast cancer(OncoTartis)

JAPAN BREAST CANCER RESEARCH GROUP

Japan

ANZ BREAST CANCER TRIALS GROUP LIMITED

Australia

International Breast Cancer Research Foundation

United States

Margetuximab Not Cost-Effective Compared to Trastuzumab for ERBB2-Positive Advanced Breast Cancer

High TIL Levels Could Enable Shorter Trastuzumab Treatment in Early ERBB2-Positive Breast Cancer

Dendritic Cell Immunotherapy Shows Promise in Early-Stage ERBB2-Positive Breast Cancer